Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
C5A-C51H9 | Cynomolgus | Cynomolgus Complement C5a Protein, His Tag |
|
||
C5A-H51H9 | Human | Human Complement C5a Protein, His Tag |
|
||
C5A-H525a | Human | Human Complement C5a Protein, Fc Tag (MALS verified) |
|
||
C5A-C5118 | Cynomolgus | Cynomolgus Complement C5a Protein, Tag Free |
|
||
C5A-M51H4 | Mouse | Mouse Complement C5a Protein, His Tag |
|
||
C5A-H5116 | Human | Human Complement C5a Protein, Tag Free |
|
Immobilized Human Complement C5a, His Tag (Cat. No. C5A-H51H9) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Human C5a Human Antibody, Human IgG1 with a linear range of 0.1-4 ng/ml (QC tested).
The purity of Human Complement C5a, Fc Tag (Cat. No. C5A-H525a) is more than 90% and the molecular weight of this protein is around 80-90 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Vilobelimab | CaCP-29; IFX-1 | Phase 3 Clinical | Inflarx Nv | Granulomatosis with Polyangiitis; Shock, Septic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Drug-Related Side Effects and Adverse Reactions; Microscopic Polyangiitis; Pyoderma Gangrenosum; Sepsis; Coronavirus Disease 2019 (COVID-19); Lung Diseases, Interstitial; Hidradenitis Suppurativa; Systemic Inflammatory Response Syndrome | Details |
BDB-001 | BDB-1; BDB-001; BDB001; BDB 001 | Phase 3 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Coronavirus Disease 2019 (COVID-19); Hidradenitis Suppurativa | Details |
STSA-1002 | STSA-1002; STSA1002 | Phase 2 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult | Details |
Vilobelimab | CaCP-29; IFX-1 | Phase 3 Clinical | Inflarx Nv | Granulomatosis with Polyangiitis; Shock, Septic; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Drug-Related Side Effects and Adverse Reactions; Microscopic Polyangiitis; Pyoderma Gangrenosum; Sepsis; Coronavirus Disease 2019 (COVID-19); Lung Diseases, Interstitial; Hidradenitis Suppurativa; Systemic Inflammatory Response Syndrome | Details |
BDB-001 | BDB-1; BDB-001; BDB001; BDB 001 | Phase 3 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Coronavirus Disease 2019 (COVID-19); Hidradenitis Suppurativa | Details |
STSA-1002 | STSA-1002; STSA1002 | Phase 2 Clinical | Staidson(Beijing) Biopharmaceuticals Co Ltd | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult | Details |
This web search service is supported by Google Inc.